| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,861 |
7,913 |
$1.67M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,306 |
4,565 |
$1.38M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
504 |
457 |
$493K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,389 |
1,192 |
$443K |
| 70450 |
Computed tomography, head or brain; without contrast material |
600 |
524 |
$189K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,973 |
1,792 |
$172K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,810 |
2,372 |
$133K |
| 71045 |
Radiologic examination, chest; single view |
1,924 |
1,687 |
$92K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,300 |
1,050 |
$84K |
| 80053 |
Comprehensive metabolic panel |
7,855 |
6,637 |
$64K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,542 |
1,446 |
$59K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,134 |
916 |
$54K |
| 85027 |
|
9,052 |
7,444 |
$53K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,054 |
1,722 |
$47K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
528 |
502 |
$31K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,139 |
962 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
361 |
325 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,753 |
1,557 |
$25K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
488 |
450 |
$25K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
287 |
218 |
$23K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
30 |
25 |
$19K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
375 |
301 |
$14K |
| 80061 |
Lipid panel |
846 |
790 |
$11K |
| 80306 |
|
469 |
411 |
$11K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
358 |
331 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
200 |
156 |
$11K |
| 81001 |
|
3,452 |
2,991 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
337 |
312 |
$10K |
| 84484 |
|
1,445 |
1,127 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,334 |
2,910 |
$8K |
| 83690 |
|
1,334 |
1,123 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
78 |
64 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
886 |
800 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
260 |
231 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
861 |
752 |
$6K |
| 86780 |
|
437 |
404 |
$6K |
| 83735 |
|
1,313 |
1,101 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
222 |
202 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
222 |
202 |
$6K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
584 |
201 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
2,744 |
2,383 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
750 |
629 |
$5K |
| 81025 |
|
630 |
542 |
$4K |
| 96376 |
|
87 |
59 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
143 |
131 |
$4K |
| 83880 |
|
194 |
163 |
$4K |
| 83605 |
|
457 |
374 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
254 |
235 |
$3K |
| 84703 |
|
361 |
315 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
129 |
107 |
$3K |
| 86703 |
|
205 |
197 |
$3K |
| 87634 |
|
59 |
57 |
$3K |
| 86803 |
|
163 |
147 |
$2K |
| 11721 |
|
79 |
73 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
155 |
142 |
$2K |
| 87040 |
|
266 |
208 |
$2K |
| 85610 |
|
520 |
407 |
$2K |
| 86850 |
|
157 |
131 |
$2K |
| 73630 |
|
28 |
27 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
232 |
222 |
$2K |
| 87077 |
|
197 |
178 |
$2K |
| 72100 |
|
31 |
28 |
$1K |
| 87186 |
|
175 |
153 |
$1K |
| 84439 |
|
141 |
131 |
$1K |
| 87340 |
|
113 |
99 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
17 |
14 |
$962.14 |
| 86762 |
|
60 |
55 |
$910.59 |
| 73110 |
|
12 |
12 |
$890.06 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
176 |
150 |
$881.15 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
551 |
478 |
$849.86 |
| 73130 |
|
14 |
12 |
$830.73 |
| 86787 |
|
60 |
55 |
$799.20 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
18 |
12 |
$787.09 |
| 73610 |
|
17 |
12 |
$786.57 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
227 |
189 |
$781.86 |
| 74018 |
|
13 |
13 |
$654.42 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
43 |
40 |
$620.84 |
| 73030 |
|
15 |
12 |
$572.80 |
| 11719 |
|
26 |
25 |
$541.82 |
| 86901 |
|
162 |
135 |
$453.88 |
| 86900 |
|
162 |
135 |
$453.78 |
| 85730 |
|
98 |
87 |
$374.82 |
| 82607 |
|
15 |
14 |
$337.41 |
| 85379 |
|
44 |
39 |
$312.67 |
| J3490 |
Unclassified drugs |
812 |
616 |
$306.20 |
| 84702 |
|
32 |
24 |
$290.00 |
| 11720 |
|
14 |
13 |
$283.23 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
14 |
13 |
$281.97 |
| Q3014 |
Telehealth originating site facility fee |
36 |
19 |
$220.01 |
| 82728 |
|
12 |
12 |
$196.02 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
22 |
18 |
$133.27 |
| 85651 |
|
32 |
28 |
$108.85 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
31 |
25 |
$101.97 |
| 82950 |
|
15 |
14 |
$77.33 |
| 86140 |
|
14 |
13 |
$60.93 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
32 |
25 |
$42.59 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
14 |
$39.81 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
34 |
31 |
$33.35 |
| 81003 |
|
14 |
12 |
$23.76 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
23 |
12 |
$17.84 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
76 |
62 |
$0.00 |
| 82077 |
|
25 |
25 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
41 |
36 |
$0.00 |